Clinical Trial Update: Endogenous Progenitors Cell Therapy for Diabetic Foot Ulcers [Phase 1]

View source ↗

Summary

Phase 1 trial of Endogenous Progenitors Cell Therapy for diabetic foot ulcers has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcers

Drugs mentioned

• Endogenous Progenitors Cell Therapy

Snippet

Sponsor: NYU Langone Health | Conditions: Diabetic Ulcer | Phase 1 | Status: WITHDRAWN